Multidetector Computed Tomography (MDCT) Evaluation of Obstructive Jaundice: A Cross-sectional Study From a Tertiary Hospital of Nepal
1 other identifier
observational
30
1 country
1
Brief Summary
This study was done to evaluate the diagnostic statistics of MDCT and its features in the assessment of obstructive jaundice in reference to surgical or histopathological diagnosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 8, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 7, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2020
CompletedFirst Submitted
Initial submission to the registry
June 16, 2023
CompletedFirst Posted
Study publicly available on registry
June 26, 2023
CompletedJune 26, 2023
June 1, 2023
1 year
June 16, 2023
June 16, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluate the diagnostic statistics of MDCT and its features in the assessment of obstructive jaundice in reference to surgical or histopathological diagnosis.
one year
Study Arms (1)
Patient presenting with obstructive jaundice referred for CT evaluation
Interventions
CT scan study of abdomen
Eligibility Criteria
30 All patients exhibiting clinical and biochemical features of obstructive jaundice who were referred for MDCT scan and subsequently received a final diagnosis through histopathology, cytopathology or surgical findings were included as participants in the study
You may qualify if:
- Any patient referred for CT scan with findings suggestive of obstructive jaundice with pertinent Histopathological and post-surgical findings .
You may not qualify if:
- Patients with contraindications for contrast-enhanced CT, those with non-obstructive cases of jaundice, and patients experiencing recurrent malignancy causing obstructive jaundice.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shree Birendra Hospitallead
- B.P. Koirala Institute of Health Sciencescollaborator
Study Sites (1)
BP Koirala Institute of Health Sciences
Dharān, Koshi, Nepal
Study Officials
- PRINCIPAL INVESTIGATOR
Asim Mahat, MD
Nepalese Army Institute of Health Sciences
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
June 16, 2023
First Posted
June 26, 2023
Study Start
October 8, 2019
Primary Completion
October 7, 2020
Study Completion
October 10, 2020
Last Updated
June 26, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share